All-Atom Models for the Non-Nucleoside Binding Site of HIV-1 Reverse Transcriptase Complexed with Inhibitors:  A 3D QSAR Approach

• Rick Gussio

  Frederick Biomedical Supercomputing Center, Structural Biochemistry Program, and Developmental Therapeutics Program, National Cancer Institute-FCRDC, SAIC Frederick, P.O. Box B, Frederick, Maryland 21702, and Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 23298

• Nagarajan Pattabiraman

  Frederick Biomedical Supercomputing Center, Structural Biochemistry Program, and Developmental Therapeutics Program, National Cancer Institute-FCRDC, SAIC Frederick, P.O. Box B, Frederick, Maryland 21702, and Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 23298

• Daniel W. Zaharevitz

  Frederick Biomedical Supercomputing Center, Structural Biochemistry Program, and Developmental Therapeutics Program, National Cancer Institute-FCRDC, SAIC Frederick, P.O. Box B, Frederick, Maryland 21702, and Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 23298

• Glen E. Kellogg

  Frederick Biomedical Supercomputing Center, Structural Biochemistry Program, and Developmental Therapeutics Program, National Cancer Institute-FCRDC, SAIC Frederick, P.O. Box B, Frederick, Maryland 21702, and Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 23298

• Igor A. Topol

  Frederick Biomedical Supercomputing Center, Structural Biochemistry Program, and Developmental Therapeutics Program, National Cancer Institute-FCRDC, SAIC Frederick, P.O. Box B, Frederick, Maryland 21702, and Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 23298

• William G. Rice

  Frederick Biomedical Supercomputing Center, Structural Biochemistry Program, and Developmental Therapeutics Program, National Cancer Institute-FCRDC, SAIC Frederick, P.O. Box B, Frederick, Maryland 21702, and Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 23298

• Catherine A. Schaeffer

  Frederick Biomedical Supercomputing Center, Structural Biochemistry Program, and Developmental Therapeutics Program, National Cancer Institute-FCRDC, SAIC Frederick, P.O. Box B, Frederick, Maryland 21702, and Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 23298

• John W. Erickson

  Frederick Biomedical Supercomputing Center, Structural Biochemistry Program, and Developmental Therapeutics Program, National Cancer Institute-FCRDC, SAIC Frederick, P.O. Box B, Frederick, Maryland 21702, and Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 23298

• Stanley K. Burt

  Frederick Biomedical Supercomputing Center, Structural Biochemistry Program, and Developmental Therapeutics Program, National Cancer Institute-FCRDC, SAIC Frederick, P.O. Box B, Frederick, Maryland 21702, and Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 23298

収録刊行物

• Journal of Medicinal Chemistry

  Journal of Medicinal Chemistry 39 (8), 1645-1650, 1996-01-01

  American Chemical Society (ACS)

キーワード

• Drug Discovery
• Molecular Medicine

詳細情報

• CRID: 1361699994827330944
• NII論文ID: 30011365654
• DOI: 10.1021/jm9508088
• ISSN: 15204804
• ISSN: 00222623
• Web Site: https://pubs.acs.org/doi/pdf/10.1021/jm9508088
• データソース種別:
  • Crossref
  • CiNii Articles